Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Products
  • Cinacalcet Hydrochloride Tablets
Where it was sold

Nationwide in the US

Nationwide

Units affected
63,504 bottles
About this recall
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02